The lysosome as a command-and-control center for cellular metabolism

CY Lim, R Zoncu - Journal of Cell Biology, 2016 - rupress.org
Lysosomes are membrane-bound organelles found in every eukaryotic cell. They are widely
known as terminal catabolic stations that rid cells of waste products and scavenge metabolic …

Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers

EC Kauffman, CJ Ricketts, S Rais-Bahrami… - Nature Reviews …, 2014 - nature.com
Despite nearly two decades passing since the discovery of gene fusions involving TFE3 or
TFEB in sporadic renal cell carcinoma (RCC), the molecular mechanisms underlying the …

The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia

JR Srigley, B Delahunt, JN Eble, L Egevad… - The American journal …, 2013 - journals.lww.com
The classification working group of the International Society of Urological Pathology
consensus conference on renal neoplasia was in charge of making recommendations …

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma

G Sun, J Chen, J Liang, X Yin, M Zhang, J Yao… - Nature …, 2021 - nature.com
TFE3-translocation renal cell carcinoma (TFE3-tRCC) is a rare and heterogeneous subtype
of kidney cancer with no standard treatment for advanced disease. We describe …

MiT family translocation renal cell carcinoma

P Argani - Seminars in diagnostic pathology, 2015 - Elsevier
The MiT subfamily of transcription factors includes TFE3, TFEB, TFC, and MiTF. Gene
fusions involving two of these transcription factors have been identified in renal cell …

TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers

P Argani, M Zhong, VE Reuter, JT Fallon… - The American journal …, 2016 - journals.lww.com
Xp11 translocation cancers include Xp11 translocation renal cell carcinoma (RCC), Xp11
translocation perivascular epithelioid cell tumor (PEComa), and melanotic Xp11 …

Proteogenomic characterization of MiT family translocation renal cell carcinoma

Y Qu, X Wu, A Anwaier, J Feng, W Xu, X Pei… - Nature …, 2022 - nature.com
Microphthalmia transcription factor (MiT) family translocation renal cell carcinoma (tRCC) is
a rare type of kidney cancer, which is not well characterized. Here we show the …

Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management

B Shuch, S Vourganti, CJ Ricketts… - Journal of clinical …, 2014 - ascopubs.org
Purpose Approximately 5% to 8% of renal cell carcinoma (RCC) is hereditary. No guidelines
exist for patient selection for RCC germline mutation testing. We evaluate how age of onset …

[HTML][HTML] Current approaches for avoiding the limitations of circulating tumor cells detection methods—implications for diagnosis and treatment of patients with solid …

A Kowalik, M Kowalewska, S Góźdź - Translational Research, 2017 - Elsevier
Eight million people die of cancer each year and 90% of deaths are caused by systemic
disease. Circulating tumor cells (CTCs) contribute to the formation of metastases and thus …

Translocation carcinomas of the kidney

P Argani - Genes, Chromosomes and Cancer, 2022 - Wiley Online Library
The MiT subfamily of transcription factors includes TFE3, TFEB, TFEC, and MITF. Gene
fusions involving two of these transcription factors have been well‐characterized in renal cell …